mRNA Vaccines for Animals Market Size, Share & Trends Analysis Distribution by Animal Type (Livestock Animals and Companion Animals), by Administration Route (Injectable and Non Invasive), by Delivery Technology (Lipid Nanoparticles (LNPs) and Viral Vectors), by Disease Indication (Avian Influenza, Swine Fever, and Canine Diseases), by End User (Veterinary Hospitals & Clinics, Research Institutes, and Farms), and Segment Forecasts, 2025-2034

Report Id: 3229 Pages: 180 Last Updated: 23 October 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of mRNA Vaccines for Animals Market -

mRNA Vaccines for Animals Market by Animal Type

·       Livestock

·       Companion Animals

mRNA Vaccines for Animals Market Seg

mRNA Vaccines for Animals Market by Administration Route

·       Injectable

·       Non Invasive

mRNA Vaccines for Animals Market by Delivery Technology

·       Lipid Nanoparticles (LNPs)

·       Viral Vectors

mRNA Vaccines for Animals Market by Disease Indication

·       Avian Influenza

·       Swine Fever

·       Canine Diseases

mRNA Vaccines for Animals Market by End User

·       Veterinary Hospitals & Clinics

·       Research Institutes

·       Farms

mRNA Vaccines for Animals Market by Region

North America-

·       The US

·       Canada

Europe-

·       Germany

·       The UK

·       France

·       Italy

·       Spain

·       Rest of Europe

Asia-Pacific-

·       China

·       Japan

·       India

·       South Korea

·       Southeast Asia

·       Rest of Asia Pacific

Latin America-

·       Brazil

·       Mexico

·       Rest of Latin America

 Middle East & Africa-

·       GCC Countries

·       South Africa

·       Rest of the Middle East and Africa

Chapter 1.    Methodology and Scope

1.1.    Research Methodology
1.2.    Research Scope & Assumptions

Chapter 2.    Executive Summary

Chapter 3.    Global mRNA Vaccines for Animals Market Snapshot

Chapter 4.    Global mRNA Vaccines for Animals Market Variables, Trends & Scope

4.1.    Market Segmentation & Scope
4.2.    Drivers
4.3.    Challenges
4.4.    Trends 
4.5.    Investment and Funding Analysis 
4.6.    Porter's Five Forces Analysis
4.7.    Incremental Opportunity Analysis (US$ MN), 2025-2034 
4.8.    Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.9.    Use/impact of AI on mRNA Vaccines for Animals Market Industry Trends 
4.10.    Global mRNA Vaccines for Animals Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034

Chapter 5.    mRNA Vaccines for Animals Market Segmentation 1: By Animal Type, Estimates & Trend Analysis

5.1.    Market Share by Animal Type, 2024 & 2034
5.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Animal Type:

5.2.1.    Livestock 
5.2.2.    Companion Animals
5.2.3.    Poultry

Chapter 6.    mRNA Vaccines for Animals Market Segmentation 2: By Administration Route, Estimates & Trend Analysis
6.1.    Market Share by Administration Route, 2024 & 2034
6.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Administration Route:
6.2.1.    Injectable
6.2.2.    Non Invasive
Chapter 7.    mRNA Vaccines for Animals Market Segmentation 3: By Delivery Technology, Estimates & Trend Analysis

7.1.    Market Share by Delivery Technology, 2024 & 2034
7.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Delivery Technology:

7.2.1.    Lipid Nanoparticles (LNPs)
7.2.2.    Viral Vectors

Chapter 8.    mRNA Vaccines for Animals Market Segmentation 4: By Disease Indication, Estimates & Trend Analysis

8.1.    Market Share by Disease Indication, 2024 & 2034
8.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Disease Indication:

8.2.1.    Avian Influenza
8.2.2.    Swine Fever
8.2.3.    Canine Diseases

Chapter 9.    mRNA Vaccines for Animals Market Segmentation 5: By End User, Estimates & Trend Analysis

9.1.    Market Share by End User, 2024 & 2034
9.2.    Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:

9.2.1.    Veterinary Hospitals & Clinics
9.2.2.    Research Institutes
9.2.3.    Farms

Chapter 10.    mRNA Vaccines for Animals Market Segmentation 6: Regional Estimates & Trend Analysis

10.1.    Global mRNA Vaccines for Animals Market, Regional Snapshot 2024 & 2034

10.2.    North America

10.2.1.    North America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

10.2.1.1.    US
10.2.1.2.    Canada

10.2.2.    North America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
10.2.3.    North America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Administration Route, 2021-2034
10.2.4.    North America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Delivery Technology, 2021-2034
10.2.5.    North America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
10.2.6.    North America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
10.2.7.    North America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

10.3.    Europe

10.3.1.    Europe mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

10.3.1.1.    Germany
10.3.1.2.    U.K.
10.3.1.3.    France
10.3.1.4.    Italy
10.3.1.5.    Spain
10.3.1.6.    Rest of Europe

10.3.2.    Europe mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
10.3.3.    Europe mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Administration Route, 2021-2034
10.3.4.    Europe mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Delivery Technology, 2021-2034
10.3.5.    Europe mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
10.3.6.    Europe mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

10.4.    Asia Pacific

10.4.1.    Asia Pacific mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

10.4.1.1.    India 
10.4.1.2.    China
10.4.1.3.    Japan
10.4.1.4.    Australia
10.4.1.5.    South Korea
10.4.1.6.    Hong Kong
10.4.1.7.    Southeast Asia
10.4.1.8.    Rest of Asia Pacific

10.4.2.    Asia Pacific mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
10.4.3.    Asia Pacific mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Administration Route, 2021-2034
10.4.4.    Asia Pacific mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Delivery Technology, 2021-2034
10.4.5.    Asia Pacific mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
10.4.6.    Asia Pacific mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

10.5.    Latin America

10.5.1.    Latin America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

10.5.1.1.    Brazil
10.5.1.2.    Mexico
10.5.1.3.    Rest of Latin America

10.5.2.    Latin America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
10.5.3.    Latin America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Administration Route, 2021-2034
10.5.4.    Latin America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Delivery Technology, 2021-2034
10.5.5.    Latin America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
10.5.6.    Latin America mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

10.6.    Middle East & Africa 

10.6.1.    Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

10.6.1.1.    GCC Countries
10.6.1.2.    Israel
10.6.1.3.    South Africa
10.6.1.4.    Rest of Middle East and Africa

10.6.2.    Middle East & Africa mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
10.6.3.    Middle East & Africa mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Administration Route, 2021-2034
10.6.4.    Middle East & Africa mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Delivery Technology, 2021-2034
10.6.5.    Middle East & Africa mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
10.6.6.    Middle East & Africa mRNA Vaccines for Animals Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

Chapter 11.    Competitive Landscape

11.1.    Major Mergers and Acquisitions/Strategic Alliances
11.2.    Company Profiles

11.2.1.    Zoetis Inc.
11.2.1.1.    Business Overview
11.2.1.2.    Key Product /Service Overview
11.2.1.3.    Financial Performance
11.2.1.4.    Geographical Presence
11.2.1.5.    Recent Developments with Business Strategy
11.2.2.    Elanco Animal Health
11.2.3.    Boehringer Ingelheim Animal Health
11.2.4.    CureVac AG
11.2.5.    Moderna, Inc.
11.2.6.    GSK (GlaxoSmithKline Animal Health)
11.2.7.    Vaxxas Pty Ltd
11.2.8.    Agenus Inc.
11.2.9.    Arcturus Therapeutics
11.2.10.    Inovio Pharmaceuticals 

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
9807
Security Code field cannot be blank!

Frequently Asked Questions

The mRNA vaccines for animals market size is valued at US$ 80.7 Mn in 2024 and is predicted to reach US$ 7,451.5 Mn by the year 2034 at an 57.6% CAGR over the forecast period.

The major players in the mRNA vaccines for animals market are Elanco Animal Health, Boehringer Ingelheim Animal Health, CureVac AG, Moderna, Inc., GSK (GlaxoSmithKline Animal Health), Vaxxas Pty Ltd, Agenus Inc., Arcturus Therapeutics, and Inovio Pharmaceuticals.

The primary mRNA vaccines for animals market segments are animal type, administration route, delivery technology, disease indication, and end user.

North America leads the market for mRNA vaccines for animals due to advanced veterinary healthcare infrastructure, high adoption of innovative animal health technologies, and strong investment in biotechnology.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying